Free Trial

ReShape Lifesciences (RSLS) Institutional Ownership

→ How a $0.25 cent option contract makes my top traders feel (From DTI) (Ad)
Free RSLS Stock Alerts
$0.18
+0.01 (+5.95%)
(As of 04/25/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for ReShape Lifesciences (NASDAQ:RSLS)

Current
Institutional Ownership
Percentage
22.06%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$63.54K
Number of
Institutional Sellers
(last 12 months)
0
Get RSLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling ReShape Lifesciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RSLS Institutional Buying and Selling by Quarter

ReShape Lifesciences Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2023Armistice Capital LLC188,000$64K0.0%N/A5.449%
5/11/2022GSA Capital Partners LLP36,490$43K0.0%N/A0.196%
11/15/2021Sassicaia Capital Advisers LLC10,000$29K0.1%N/A0.063%
8/17/2021Armistice Capital LLC816,527$4.08M0.1%N/A24.447%
8/16/2021State Street Corp109,999$550K0.0%N/A3.293%
8/13/2021Alpine Global Management LLC17,000$85K0.0%N/A0.509%
8/13/2021Geode Capital Management LLC23,277$116K0.0%N/A0.697%
8/13/2021Vanguard Group Inc.51,120$256K0.0%N/A1.531%
(Data available from 1/1/2016 forward)

RSLS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RSLS shares?

During the previous two years, the following institutional investors and hedge funds held shares of ReShape Lifesciences shares: Armistice Capital LLC ($64K), GSA Capital Partners LLP ($43K).Learn more on RSLS's institutional investors.

What percentage of ReShape Lifesciences stock is owned by institutional investors?

22.06% of ReShape Lifesciences stock is owned by institutional investors. Learn more on RSLS's institutional investor holdings.

Which institutional investors have been buying ReShape Lifesciences stock?

The following institutional investors have purchased ReShape Lifesciences stock in the last 24 months: Armistice Capital LLC ($188K), and GSA Capital Partners LLP ($36.49K).

How much institutional buying is happening at ReShape Lifesciences?

Institutional investors have bought a total of 224,490 shares in the last 24 months. This purchase volume represents approximately $2.22M in transactions.


Related Companies:
This page (NASDAQ:RSLS) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Your Money is Not Safe
American Alternative
Fed launches fourth dollar overhaul
Stansberry Research
The only accurate crypto trading system I know …
Weiss Ratings